Peter Salgo, MD; John L. Fox, MD, MHA; Michael Kolodziej, MD; Ira M. Klein, MD, MBA, FACP; Bryan Loy, MD; and Irwin W. Tischler, DO, agree that multiple sources and varying formats of data collection are preventing payers from utilizing available data to make informed treatment decisions in oncology.
The panelists discuss currently available data integration platforms that may help with data harmonization and clinical support. Dr Loy comments that although various database platforms are available, their use is limited due to infrastructure problems.
When analyzing the costs of care, patient-centric records that provide information about a patient’s entire continuum of care are important, as patients may receive treatment at multiple institutions from multiple physicians, notes Dr Fox.
To address the need for data regarding total cost of care, Dr Salgo highlights the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database and its link to Medicare data. The SEER database provides information regarding a patient’s initial diagnosis and overall treatment regimen, notes Dr Salgo.
However, Dr Kolodziej remarks that there are limitations in terms of how the SEER data are collected and the completeness of the data. Drs Klein and Fox add that although great in principle, the SEER database is not nationally representative. Together, they conclude that there is an unmet need for a database that captures all necessary data, and that it remains unclear what organizations would be responsible for funding and maintaining such a database.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More